| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | NOKIA CORP | 11,850 | 67,000 | 0.04% | ||
| 102 | AMICUS THERAPEUTICS INC COM | 11,200 | 61,000 | 0.04% | ||
| 103 | CLIFFS NAT RES INC | 10,052 | 57,000 | 0.04% | ||
| 104 | MILESTONE SCIENTIFIC INC | 17,857 | 50,000 | 0.03% | ||
| 105 | PEREGRINE PHARMACEUTICALS IN | 15,000 | 5,000 | 0.00% | ||
| 106 | DYAX CORP COM CVR | 28,950 | 0 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001482611-16-000033, filed 2016.07.08).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.